Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 804 participants.
Also called NCT04459117
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 804 participants
- Registry
-
NCT04459117 -
2019-004297-26
-
- Other papers using this trial's data
- Prophylactic Intravenous Acetaminophen in Extremely Premature Infants: Minimum Effective Dose Research by Bayesian Approach
- Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Denmark, Estonia, Finland, France, Hungary, Ireland, Italy, Norway, Portugal, Sweden, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT04459117. Randomized; quadruple masking; primary purpose treatment. Start 2020-10-29 (actual); primary completion 2024-06-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
- Acronym
- TREOCAPA
- Condition
- Patency of the Ductus Arteriosus
- Condition
- Acetaminophen
- Condition
- Extreme Prematurity
- Intervention (Drug)
- Acetaminophen
- Intervention (Drug)
- NACL 0.9%
- Lead sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Collaborator
- UPCET
- Collaborator
- PARTNERS for International clinical Research
- Collaborator
- Connect for Children
- Collaborator
- Global Foundation for the Care of Newborn Infants
Record details
- Record id
cardio:ct-nct04459117- Content hash
3176241990b68afd3ef422a08c2a11dbc1571ed974cf94441c7ac09b777ef20b